Corticosteroid

FDA Approves Drug to Treat Duchenne Muscular Dystrophy

Feb 10, 2017 at 08:10 am by Staff

On Feb. 9, the U.S. Food and Drug Administration approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dyst.... Read More